We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

86 hedge funds and large institutions have $43.1M invested in Praxis Precision Medicines in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 19

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

0.35% more ownership

Funds ownership: 6.43% → 6.77% (+0.35%)

17% less funds holding

Funds holding: 103 → 86 (-17)

59% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 29

60% less capital invested

Capital invested by funds: $108M → $43.1M (-$64.7M)

92% less call options, than puts

Call options by funds: $17K | Put options by funds: $204K

Holders
86
Holders Change
-17
Holders Change %
-16.5%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
12
Increased
39
Reduced
19
Closed
29
Calls
$17K
Puts
$204K
Net Calls
-$187K
Net Calls Change
-$191K

Top Buyers

1
VCIM
Velan Capital Investment Management
Georgia
+$14.6M
2
APM
Avidity Partners Management
Texas
+$12M
3
Bank of America
Bank of America
North Carolina
+$7.07M
4
TLP
Tri Locum Partners
New York
+$6.93M
5
GPP
Great Point Partners
Connecticut
+$5.72M

Top Sellers

1
Blackstone Inc
Blackstone Inc
New York
-$10.8M
2
EAM
Eventide Asset Management
Massachusetts
-$8.37M
3
EC
EcoR1 Capital
California
-$3.77M
4
AG
Artal Group
Luxembourg
-$2.86M
5
OCA
Octagon Capital Advisors
New York
-$1.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
VCIM
1
Velan Capital Investment Management
Georgia
$4.19M +$14.6M +345,667 New
KCM
2
Kingdon Capital Management
New York
$3.8M +$5.19M +122,934 +65%
APM
3
Avidity Partners Management
Texas
$3.46M +$12M +285,447 New
Bank of America
4
Bank of America
North Carolina
$3.26M +$7.07M +167,390 +166%
Verition Fund Management
5
Verition Fund Management
Connecticut
$2.4M +$3.64M +86,131 +77%
BlackRock
6
BlackRock
New York
$2.34M -$235K -5,565 -3%
TLP
7
Tri Locum Partners
New York
$2.01M +$6.93M +164,280 +10,204%
PHS
8
PFM Health Sciences
California
$1.76M -$1.69M -40,058 -22%
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.73M +$995K +23,574 +20%
GPP
10
Great Point Partners
Connecticut
$1.64M +$5.72M +135,503 New
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$1.56M -$939K -22,252 -15%
BBA
12
Baker Bros. Advisors
New York
$1.52M +$140K +3,307 +3%
VVA
13
Vida Ventures Advisors
Massachusetts
$1.19M – – –
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$1.13M +$121K +2,859 +3%
CIBC Asset Management
15
CIBC Asset Management
Ontario, Canada
$1.04M +$2.55M +60,322 +238%
Blackstone Inc
16
Blackstone Inc
New York
$854K -$10.8M -256,000 -78%
7IH
17
72 Investment Holdings
Connecticut
$800K – – –
State Street
18
State Street
Massachusetts
$784K +$233K +5,518 +9%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$676K +$400K +9,466 +20%
Morgan Stanley
20
Morgan Stanley
New York
$670K +$1.82M +43,099 +355%
HMC
21
Harvard Management Company
Massachusetts
$630K – – –
Goldman Sachs
22
Goldman Sachs
New York
$615K +$116K +2,749 +6%
Citadel Advisors
23
Citadel Advisors
Florida
$505K -$370K -8,769 -17%
SSA
24
Schonfeld Strategic Advisors
New York
$430K +$1.3M +30,915 +683%
UOC
25
UBS O'Connor
Illinois
$410K +$1.43M +33,817 New
1
2 3 4 5

PRAX Hedge Fund Activity: Q1 2023 in Review

86 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q1 2023, worth a combined $43.1M — down 60% from $108M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of PRAX and 12 opened new positions — a net loss of 17 holders — while 19 trimmed existing stakes and 39 added.

The largest buyer was Velan Capital Investment Management, opening a new position worth an estimated $14.6M. The largest seller was Blackstone Inc, cutting an estimated $10.8M.

  • 86 institutional investors held Praxis Precision Medicines (PRAX) as of Q1 2023, down from 103 in Q4 2022.
  • Funds reported $43.1M of Praxis Precision Medicines stock for Q1 2023, down 60% quarter-over-quarter.
  • 12 funds opened new Praxis Precision Medicines positions in Q1 2023 and 29 closed out, a net change of -17 holders.
  • The largest Praxis Precision Medicines buyer in Q1 2023 was Velan Capital Investment Management, an estimated $14.6M added.
  • The largest Praxis Precision Medicines seller in Q1 2023 was Blackstone Inc, an estimated $10.8M sold.

Based on aggregated 13F filings for Q1 2023.